Internal Medicine, Hematology & Oncology · Orange, CA
NPI
1356541502
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
101 the City Dr S Bldg 23
Orange, CA, 92868
Phone (714) 456-5153
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
568 services
Medicare patients, 2024
111
Average age 74
Drug cost, 2024
$2.4M
878 prescriptions
Company payments, 2025
$1,541
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deepa Jeyakumar was code 99215 (office e&m - established), 314 times for 59 patients. In total Deepa Jeyakumar billed 568 services in 11 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 314 | 59 | $121.98 | $38K |
| 99443 Telephone Services | Facility | 122 | 16 | $81.41 | $9,932 |
| 99214 Office E&M - Established | Facility | 56 | 31 | $87.07 | $4,876 |
| 99223 Hospital E&M - Initial | Facility | 32 | 30 | $152.09 | $4,867 |
| 99238 Hospital Discharge Management | Facility | 22 | 22 | $73.02 | $1,606 |
By year: 2022 $90K for 817 services; 2023 $77K for 715 services; 2024 $62K for 568 services.
Medicare prescription drug claims, 2024
In 2024, the drug Deepa Jeyakumar prescribed most often to Medicare patients was Acyclovir, with 104 prescriptions and refills. In total Deepa Jeyakumar wrote 878 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 104 | 174 | 26 | $2,273 |
| Venclexta Venetoclax | 92 | 92 | 13 | $175K |
| Levofloxacin Generic | 55 | 55 | 13 | $458 |
| Posaconazole Generic | 41 | 41 | 11 | $61K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 33 | 33 | Under 11 | $752 |
| Cresemba Isavuconazonium Sulfate | 24 | 26 | Under 11 | $153K |
| Onureg Azacitidine | 23 | 23 | Under 11 | $502K |
| Tramadol Hcl Generic | 23 | 23 | Under 11 | $70.66 |
| Potassium Chloride Generic | 22 | 38 | Under 11 | $441 |
| Lenalidomide Generic | 20 | 20 | Under 11 | $301K |
| Sprycel Dasatinib | 19 | 22 | Under 11 | $213K |
| Mirtazapine Generic | 16 | 36 | Under 11 | $142 |
| Pantoprazole Sodium Generic | 14 | 32 | Under 11 | $123 |
| Brukinsa Zanubrutinib | 12 | 12 | Under 11 | $164K |
| Finasteride Generic | 12 | 12 | Under 11 | $65.51 |
Brand drugs: - claims; generic drugs: 630 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deepa Jeyakumar $1,541 ($1,541 in general payments such as food, travel and fees) from 9 companies. The largest payer was Amgen Inc. with $1,416.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.